News items related to:
-
WHO List of Essential Medicines
The World Health Organization (WHO) updates its essential list of medicines every two years.
-
100% LIFE – 2018 Annual Report
Our partner, 100% LIFE, is the largest patient organization in Ukraine. 100% LIFE employs a range of strategies in order...
-
LACTA Community Advisory Board (CAB) – 2018 Report
Treatment activists, representing 13 countries in the Latin America and Caribbean region (LACTA), met with ViiV Healthcare in Panama City...
-
Join the Fight – Celebrating HIV Activism Then and Now
This ITPC film looks back at how we started, what’s changed and why community activism is still needed now more...
-
MedsPaL – patent information database
MedsPaL provides information on the patent and licensing status of selected HIV, Hepatitis C, TB and other patented essential medicines...
-
The Roadmap – Special Edition Report on Tenofovir Alafenamide Fumarate (TAF)
Make Medicines Affordable partner, the Initiative for Medicines, Access and Knowledge (I-MAK), has produced the Roadmap Special Edition Report on...
-
Assessment of national intellectual property landscapes and their impact on access to medicines (Egypt, Morocco, Tunisia)
This intellectual property landscapes tool developed in the MENA region can be used to assess the patent landscape in other countries.
-
Acuerdo de asociación birregional entre el Mercosur y la Unión Europea
Impacto del capítulo de propiedad intelectual sobre las compras públicas de medicamentos en la República Argentina. El presente trabajo tiene...
-
EU-Mercosur Bi-regional Association Agreement
The impact of intellectual property on public procurement of medicines in Argentina. This report analyzes the potential impact on access...
-
Estimated costs and prices of essential medicines
Research from the University of Liverpool estimates the costs of production and potential prices for drugs on the WHO’s Essential...
-
Global Summit on IP and Access to Medicines – 2018
All the presentations from our inaugural GSIPA2M in Marrakech, January 2018.
-
Big Pharma Drop the Case!
Argentina and Brazil launch a campaign to demand that pharmaceutical companies drop their case which threatens access to medicines and...